Analysis of first-trimester combined test results in preparation for a cell-free fetal DNA era

Conclusion cffDNA screening should be used to optimize IDT uptake in pregnancies with a risk score of 1:101–1:1000. The selective power of the FCT diminishes beyond the 1:1001 score and cffDNA screening cannot yet be recommended routinely.
Source: International Journal of Gynecology and Obstetrics - Category: OBGYN Source Type: research